Matches in Wikidata for { <http://www.wikidata.org/entity/Q37496642> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- Q37496642 description "article científic" @default.
- Q37496642 description "article scientifique" @default.
- Q37496642 description "articolo scientifico" @default.
- Q37496642 description "artigo científico" @default.
- Q37496642 description "artículu científicu espublizáu en 2016" @default.
- Q37496642 description "bilimsel makale" @default.
- Q37496642 description "scientific article published on 14 October 2016" @default.
- Q37496642 description "vedecký článok" @default.
- Q37496642 description "vetenskaplig artikel" @default.
- Q37496642 description "videnskabelig artikel" @default.
- Q37496642 description "vědecký článek" @default.
- Q37496642 description "wetenschappelijk artikel" @default.
- Q37496642 description "wissenschaftlicher Artikel" @default.
- Q37496642 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q37496642 description "научни чланак" @default.
- Q37496642 description "مقالة علمية نشرت في 14 أكتوبر 2016" @default.
- Q37496642 name "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 name "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 name "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer." @default.
- Q37496642 type Item @default.
- Q37496642 label "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 label "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 label "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer." @default.
- Q37496642 prefLabel "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 prefLabel "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 prefLabel "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer." @default.
- Q37496642 P1433 Q37496642-5210D9AE-CEB5-4C9F-B20C-17796FF7B5B3 @default.
- Q37496642 P1476 Q37496642-0C9EDBF2-547B-448C-95E6-F0247CD5BFAA @default.
- Q37496642 P2093 Q37496642-16A985CF-5B40-416F-8029-80BDD35B4551 @default.
- Q37496642 P2093 Q37496642-2FA9626F-6C44-437C-BD41-EF68BF43C3BA @default.
- Q37496642 P2093 Q37496642-3BE2C699-8B56-4FDD-8811-055EEF8AA55E @default.
- Q37496642 P2093 Q37496642-4D9674B0-4006-4B60-8387-B83F3B4310C1 @default.
- Q37496642 P2093 Q37496642-5971CAB3-C833-433B-B2B9-A2F5992EC94D @default.
- Q37496642 P2093 Q37496642-82B1C6F3-7541-45DA-AFF6-672C1FC1B4A7 @default.
- Q37496642 P2093 Q37496642-9FC3FDA6-9B53-4EFE-BDCA-FB14BBB954BE @default.
- Q37496642 P2093 Q37496642-E239EE16-53ED-4279-9D56-4F571BD31FF4 @default.
- Q37496642 P2093 Q37496642-EAB0E09A-602D-4093-8B5B-348408F455BD @default.
- Q37496642 P2860 Q37496642-138D26BD-C118-4420-BDA1-3B735E2EFCB3 @default.
- Q37496642 P2860 Q37496642-14C1C756-38D6-4720-BEE8-79AF7C27FD72 @default.
- Q37496642 P2860 Q37496642-482E9416-EEFF-4132-AC02-9BF1B816A35A @default.
- Q37496642 P2860 Q37496642-48D8A4BB-E5CA-45D9-B0D2-459EB3493859 @default.
- Q37496642 P2860 Q37496642-54CE96FA-554C-44AF-9693-628FA34E97CA @default.
- Q37496642 P2860 Q37496642-D2C8671B-25A9-4073-B480-5ACD73E00A7D @default.
- Q37496642 P2860 Q37496642-E0917E64-7757-4710-AEBD-AF823FE0AB04 @default.
- Q37496642 P2860 Q37496642-E8F4F942-776D-4644-8295-6FCB60326E4D @default.
- Q37496642 P304 Q37496642-91D886AF-C832-48EE-8F33-9AB9D490EFE0 @default.
- Q37496642 P31 Q37496642-038D5B4F-13B6-4A2A-8254-8D4851969DD2 @default.
- Q37496642 P356 Q37496642-339C62A5-9535-4C4C-90B2-322098F156AD @default.
- Q37496642 P433 Q37496642-94F740CA-A487-4916-83E9-7D44C9512CC1 @default.
- Q37496642 P478 Q37496642-E130BC52-229A-4475-8451-C99C4A5C5421 @default.
- Q37496642 P577 Q37496642-E8F1F113-92A2-49A4-B484-EDB9973757F6 @default.
- Q37496642 P698 Q37496642-9FABDD02-F2B0-4DC1-96CA-3AD86F0DF52A @default.
- Q37496642 P921 Q37496642-236063F2-A31C-4409-84FB-9908785B3D8B @default.
- Q37496642 P921 Q37496642-757AD607-B7E0-435E-ACAC-7B9259CA9FB3 @default.
- Q37496642 P932 Q37496642-3985CE9D-FF97-4062-844B-D5818A803B50 @default.
- Q37496642 P356 THEONCOLOGIST.2016-0026 @default.
- Q37496642 P698 27742908 @default.
- Q37496642 P1433 Q2122327 @default.
- Q37496642 P1476 "Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer" @default.
- Q37496642 P2093 "Bobby Liaw" @default.
- Q37496642 P2093 "Che-Kai Tsao" @default.
- Q37496642 P2093 "John Sfakianos" @default.
- Q37496642 P2093 "Kiev Gimpel-Tetra" @default.
- Q37496642 P2093 "Linda Bulone" @default.
- Q37496642 P2093 "Margaret Kemeny" @default.
- Q37496642 P2093 "Matthew David Galsky" @default.
- Q37496642 P2093 "Mohammad Shahin" @default.
- Q37496642 P2093 "William Kyu Oh" @default.
- Q37496642 P2860 Q24612084 @default.
- Q37496642 P2860 Q29617512 @default.
- Q37496642 P2860 Q34751456 @default.
- Q37496642 P2860 Q35112055 @default.
- Q37496642 P2860 Q35215028 @default.
- Q37496642 P2860 Q37267225 @default.
- Q37496642 P2860 Q38096127 @default.
- Q37496642 P2860 Q44376152 @default.
- Q37496642 P304 "1414-e9" @default.
- Q37496642 P31 Q13442814 @default.
- Q37496642 P356 "10.1634/THEONCOLOGIST.2016-0026" @default.
- Q37496642 P433 "12" @default.
- Q37496642 P478 "21" @default.
- Q37496642 P577 "2016-10-14T00:00:00Z" @default.
- Q37496642 P698 "27742908" @default.
- Q37496642 P921 Q181257 @default.
- Q37496642 P921 Q42824440 @default.
- Q37496642 P932 "5153336" @default.